您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2014, Vol. 52 ›› Issue (10): 15-19.doi: 10.6040/j.issn.1671-7554.0.2014.351

• 基础医学 • 上一篇    下一篇

LPS通过PGE2-EP2信号传导通路诱导肺血管生成

张鹏飞, 徐晓娅, 姜曼, 毕玉莉, 许继映, 韩明勇   

  1. 山东大学附属省立医院肿瘤中心, 山东 济南 250021
  • 收稿日期:2014-05-30 修回日期:2014-09-19 出版日期:2014-10-10 发布日期:2014-10-10
  • 通讯作者: 韩明勇。E-mail：hanmingyong@sina.com E-mail:hanmingyong@sina.com
  • 基金资助:
    国家自然科学基金（81272351）；山东省自然科学基金（ZR2012HM020）；山东省科技发展计划（2012G0021826）

LPS induces lung angiogenesis via PGE2-EP2 pathway in mouse model

ZHANG Pengfei, XU Xiaoya, JIANG Man, BI Yuli, XU Jiying, HAN Mingyong   

  1. Cancer Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2014-05-30 Revised:2014-09-19 Online:2014-10-10 Published:2014-10-10

PDF (PC)

243

摘要： 目的 探讨脂多糖（LPS）诱导肺血管生成的相关信号途径。方法 12只6~8周龄的雌性BALB/c小鼠随机分为两组，分别行腹腔注射LPS和PBS，作为LPS组（n=6）和PBS组（n=6），建立小鼠炎症模型。采用HE染色和免疫荧光实验检测肺血管密度，应用ELISA法测定血清血管内皮生长因子（VEGF）。分离正常小鼠肺血管内皮细胞（MPVECs）并培养，分别给予VEGF、PGE2、Celecoxib、EP受体拮抗剂AH6809和4种EP受体激动剂（ONO-AE1-259-01、ONO-DI-004、ONO-AE-248、ONO-AE1-329）进行刺激，观察内皮细胞成管情况，检测培养上清液中VEGF表达水平。结果 LPS诱导小鼠肺部炎症反应及血管生成；LPS组小鼠血清VEGF水平明显高于PBS组小鼠（P<0.01）。单独使用PGE2或VEGF能促进血管生成；Celecoxib可抑制VEGF诱导的肺血管生成，仅EP2受体激动剂ONO-AE1-259-01能使MPVECs上清液中VEGF水平升高（P<0.05），而EP2受体拮抗剂AH6809抑制MPVECs培养上清液中的VEGF水平（P<0.05）。结论 LPS可以诱导小鼠肺部炎症反应，并使VEGF表达水平升高；Celecoxib可抑制血管内皮细胞VEGF的表达水平。LPS通过PGE2-EP2信号通路介导，促进血管内皮细胞产生VEGF，从而促进血管生成。

关键词: 血管生成, 动物模型, 脂多糖, PGE2-EP2途径

Abstract: Objective To investigate the mechanism by which Lipopolysaccharide (LPS) induced angiogenesis in mice lungs. Methods Twelve female BALB/c mice aged 6 to 8 weeks were divided into LPS and PBS groups randomly, which were intraperitoneally injected into LPS and PBS, respectively. Lung tissues were collected to determine the pulmonary blood vessel density by HE staining and CD31 immunofluorescence staining. Vascular endothelial growth factor (VEGF) level in serum of all mice were assayed by ELISA. Mouse pulmonary vascular endothelial cells (MPVECs) were stimulated with VEGF, PGE2, Celecoxib, EP receptor inhibitor AH6809 and EP receptor agonists (ONO-AE1-259-01, ONO-DI-004, ONO-AE-248, and ONO-AE1-329). Then culture supernatant was collected to assay VEGF expression and tube forming test was performed to observe angiogenesis of endothelial cells. Results LPS induced inflammatory response and angiogenesis in mice lungs. Serum VEGF level of LPS treated mice were higher than those of PBS treated mice (P<0.01). VEGF or PGE2 used separately could increase angiogenesis. Celecoxib reduced VEGF levels released by MPVECs and suppressed angiogenesis. VEGF production was increased by ONO-AE1-259-01 (P<0.05) and decreased by AH6809 (P<0.05). Other EP receptor agonists had no significant effects on VEGF production. Conclusion LPS can induce inflammatory response in mice lungs, and increase serum VEGF level. Celecoxib can counteract this effect. LPS promotes angiogenesis by increasing the production of VEGF via PGE2-EP2 pathway.

Key words: PGE2-EP2 pathway, Angiogenesis, Lipopolysaccharide, Animal model

中图分类号: 

  • R734.2
[1] Ikebe M, Kitaura Y, Nakamura M, et al. Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway[J]. J Surg Oncol, 2009, 100(8):725-731.
[2] He Z, Zhu Y, Jiang H. Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study[J]. Respir Res, 2009, 10: 126.
[3] Valcárcel M, Mendoza L, Hernández J J, et al. Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2[J]. J Transl Med, 2011, 9: 142.
[4] Zhao Y, Kong X, Li X, et al. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells[J]. PLoS One, 2011, 6(12): e29363. doi: 10.1371/journal.pone.0029363.
[5] Attar B M, George M, Ion-Nedelcu N, et al. Disease dependent qualitative and quantitative differences in the inflammatory response to ascites occurring in cirrhotics[J]. World J Hepatol, 2014, 6(2): 85-91.
[6] Baeriswyl V, Christofori G. The angiogenic switch in carcinogenesis[J]. Semin Cancer Biol, 2009, 19(5): 329-337.
[7] 徐晓娅, 毕玉莉, 姜曼, 等.血管内皮生长因子促进肺转移相关受体通路的研究[J].山东大学学报:医学版, 2013, 51(11): 25-29. XU Xiaoya, BI Yuli, JIANG Man, et al. Vascular endothelial growth factor (VEGF) promotes lung carcinoma metastasis via VEGFR1 in mouse model[J]. Journal of Shandong University: Health Sciences, 2013, 51(11): 25-29.
[8] Ranganathan P V, Jayakumar C, Mohamed R, et al. Netrin-1 regulates the inflammatory response of neutrophils and macrophages, and suppresses ischemic acute kidney injury by inhibiting COX-2-mediated PGE2 production[J]. Kidney Int, 2013, 83(6): 1087-1098.
[9] Weems Y S, Bridges P J, Jeoung M, et al. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. Ⅱ: mRNA for PGF2α, EP1, EP2, EP3 (AD), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue[J]. Prostaglandins Other Lipid Mediat, 2012, 97(1-2): 60-65.
[10] Morita Y, Morita N, Hata K, et al. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-c and lymph node metastasis in human oral tongue cancer[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 117(4): 502-510.
[11] Frölich S, Olliges A, Kern N, et al. Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition[J]. Am J Physiol Renal Physiol, 2012, 303(2): F209-F219.
[12] Peng M, Wang Y L, Wang F F, et al. The cyclooxygenase-2 inhibitor parecoxib inhibits surgery-induced proinflammatory cytokine expression in the hippocampus in aged rats[J]. J Surg Res, 2012, 178(1): e1-e8. doi: 10.1016/j.jss.2012.08.030.
[13] Zhao L, Wu Y, Xu Z, et al. Involvement of COX-2/PGE2 signalling in hypoxia-induced angiogenic response in endothelial cells[J]. J Cell Mol Med, 2012, 16(8): 1840-1855.
[14] Wang X, Li G, Wang A, et al. Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells[J]. Mol Carcinog, 2013, 52(3): 218-228.
[15] Nakanishi M, Sato T, Li Y, et al. Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblasts[J]. Am J Respir Cell Mol Biol, 2012, 46(2): 217-223.
[1] 于德新 蔡跃红 马祥兴 张晓明 李传福. 肝细胞癌血管生成及其成熟度的临床意义[J]. 山东大学学报(医学版), 2209, 47(6): 51-54.
[2] 胡玉敬,吴大勇,张文艳,边艳珠,魏强,田丛娜,常胜利. 放疗后肿瘤99Tcm-MNLS乏氧显像变化与乏氧诱导因子-1α表达的相关性[J]. 山东大学学报（医学版）, 2017, 55(8): 30-34.
[3] 聂思月,王震,孙靖宇,刘杰,李娟,魏小娟,路春晓,吕兴龑,王淑云,孙玉萍. ANGPTL5在人胃癌组织中的表达及临床意义[J]. 山东大学学报（医学版）, 2017, 55(8): 61-65.
[4] 尹妮,杨关林,姜钧文,王春田,王凤耀,贾连群,高晓宇,潘嘉祥,李芹,李佳,冯元洁,高玉竹,周鹤,张哲. 巴马小型猪冠状动脉粥样硬化模型的评价方法[J]. 山东大学学报（医学版）, 2017, 55(7): 1-5.
[5] 陈意坤,王克涛,王华阳,邵倩倩,谈万业,宋晓彬,曲迅,魏奉才. KIF4A对巨噬细胞血管生成相关因子表达的调节作用[J]. 山东大学学报（医学版）, 2017, 55(1): 39-43.
[6] 刘宁,吕欣,李栋,黄志伟,刘毅,张乐玲. 人血管生成素1基因慢病毒表达载体的构建及其在脐带间充质干细胞的表达[J]. 山东大学学报（医学版）, 2016, 54(12): 1-7.
[7] 吴彧,夏彦清,伍玥,孙琳,邬成业,娄桂予,李雅欣,丁松泽,孙恺. 炎性细胞模型中姜黄素对胆固醇逆转运蛋白ABCA1和ABCG1基因的影响[J]. 山东大学学报（医学版）, 2016, 54(11): 24-26.
[8] 朱震坤, 周芹, 孙睿男, 徐欣. 热休克蛋白27在脂多糖介导的牙龈成纤维细胞损伤中的表达[J]. 山东大学学报（医学版）, 2015, 53(3): 36-40.
[9] 刘洋, 王焕亮, 刘亚洋, 闫红丹, 孙宝柱, 黄珊珊, 黄瑞, 类维富. 利多卡因对脂多糖诱导小鼠巨噬细胞caspase-1和IL-1β表达的影响[J]. 山东大学学报（医学版）, 2015, 53(12): 43-46,56.
[10] 付海燕, 胡占升, 杜红阳. 白藜芦醇衍生物TMS对脂多糖诱导血管内皮细胞表达NO、ICAM-1和NF-κB的影响[J]. 山东大学学报（医学版）, 2015, 53(11): 10-15.
[11] 段林, 张晓静, 于盼盼, 于峰, 刘威, 宋宁. 八肽胆囊收缩素对脂多糖诱导的小鼠单核细胞RAW264.7细胞内质网应激的影响[J]. 山东大学学报（医学版）, 2015, 53(11): 16-20.
[12] 陈少平, 王旬果, 郭燕春, 刘瑞宝, 王芳. 重组人血管内皮抑素在晚期消化道肿瘤化疗中的应用[J]. 山东大学学报（医学版）, 2014, 52(S1): 122-124.
[13] 李燕，尉蔚，吕树卿，田永杰. PARP-1对卵巢癌血管生成的影响[J]. 山东大学学报（医学版）, 2014, 52(4): 97-101.
[14] 孟祥继，庞琦，丁锋，辛涛，杨洪安. 纹状体立体定向注射Taclo建立帕金森病大鼠模型[J]. 山东大学学报（医学版）, 2014, 52(3): 16-18.
[15] 郑帅，许豪，刘华杰，邢毅，许尚臣，庞琦. HMGA1在脑胶质瘤侵袭性及其血管生成中的作用[J]. 山东大学学报（医学版）, 2014, 52(2): 78-81.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发